RTI International and CarbonBridge Partner to Scale Gas-to-Chemicals Bioprocessing
Event summary
- RTI International and CarbonBridge Inc. have signed a memorandum of understanding to demonstrate CarbonBridge's stackable bioreactor system at RTI's Pilot Xcelerator (RPX).
- The collaboration aims to generate third-party performance data for methanol production from methane, with testing planned for 2027.
- CarbonBridge's technology converts gases like methane and carbon dioxide into fuels and chemicals using a novel bioreactor design.
- RTI will design, build, and operate automated technology validations to support scale-up and commercialization decisions.
The big picture
This collaboration aligns with the growing trend of leveraging biotechnology to create sustainable chemical products. CarbonBridge's ARPA-E backing underscores the strategic importance of its gas-to-value technology in the transition to a low-carbon economy. The partnership with RTI International provides CarbonBridge with the necessary infrastructure and expertise to validate its technology, potentially positioning it as a key player in the bioindustrial revolution.
What we're watching
- Technology Validation
- How the 2027 testing periods will impact the credibility and scalability of CarbonBridge's bioreactor system.
- Commercialization Path
- Whether RTI's support can accelerate CarbonBridge's path to commercialization in sectors like agriculture and wastewater management.
- Market Adoption
- The pace at which gas-to-value technologies will gain traction in the energy and chemical industries.
Related topics